Back
Nuveen NASDAQ 100 Dynamic Overwrite Fund Vs. Insmed Industry Stock Comparison
Buy
73
QQQX
Nuveen NASDAQ 100 Dynamic Overwrite Fund
Last Price:
25.04
Seasonality Move:
0.54%
Buy
65
INSM
Insmed
Last Price:
72.22
Seasonality Move:
4.27%
Buy
73
Nuveen NASDAQ 100 Dynamic Overwrite Fund (QQQX)
is a Buy
Is Nuveen NASDAQ 100 Dynamic Overwrite Fund a Buy, Sell or Hold?
- The current Nuveen NASDAQ 100 Dynamic Overwrite Fund [QQQX] share price is $25.03. The Score for QQQX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- QQQX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $72.28. The Score for INSM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QQQX Stock Price Chart
What is Nuveen NASDAQ 100 Dynamic Overwrite Fund's stock price today?
-
The Nuveen NASDAQ 100 Dynamic Overwrite Fund share price today is $25.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQX is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Stock Price Chart
QQQX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 55.67 | Buy |
Chaikin Money Flow: | -55799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.32 - 25.06) | Buy |
Bollinger Bands (100): | (24 - 25.12) | Buy |
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 46.34 | Sell |
Chaikin Money Flow: | 515638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.86 - 74.32) | Sell |
Bollinger Bands (100): | (51.81 - 81.07) | Buy |
QQQX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.01 | Buy |
20-day SMA: | 24.81 | Buy |
50-day SMA: | 24.46 | Buy |
200-day SMA: | 23.98 | Buy |
8-day EMA: | 24.99 | Buy |
20-day EMA: | 24.84 | Buy |
50-day EMA: | 24.65 | Buy |
200-day EMA: | 24.11 | Buy |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.58 | Sell |
20-day SMA: | 72.92 | Sell |
50-day SMA: | 73.99 | Sell |
200-day SMA: | 47.03 | Buy |
8-day EMA: | 72.53 | Sell |
20-day EMA: | 73.04 | Sell |
50-day EMA: | 71.92 | Buy |
200-day EMA: | 53.13 | Buy |
Nuveen NASDAQ 100 Dynamic Overwrite Fund Earnings Growth & QQQX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
Nuveen NASDAQ 100 Dynamic Overwrite Fund Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Insmed Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |